Chang Zu
Impact in
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Drug Solubulity and Delivery Systems 3
- Advanced Drug Delivery Systems 2
- Co-authors
- Xiuhua Zhao (9 shared papers)Yiping Deng (5 shared papers)Mingfang Wu (5 shared papers)Weiwei Wu (7 shared papers)Ziqi Feng (3 shared papers)Yuangang Zu (2 shared papers)Lingling Wang (3 shared papers)Jiasheng Tu (4 shared papers)
- Journals
- RSC Advances (2 papers)Journal of Colloid and Interface Science (1 paper)European Journal of Pharmaceutical Sciences (1 paper)International Journal of Pharmaceutics (1 paper)Journal of Biomaterials Applications (1 paper)
- Partner nations
- ChinaSlovakiaUnited States
In The Last Decade
Chang Zu
14 papers receiving 346 citations
Peers
Comparison fields: 5 of 78
- Pharmaceutical Science 74
- Biomaterials 81
- Pharmacology 36
- Complementary and alternative medicine 30
- Biomedical Engineering 97
Countries citing papers authored by Chang Zu
This map shows the geographic impact of Chang Zu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Zu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Zu more than expected).
Fields of papers citing papers by Chang Zu
This network shows the impact of papers produced by Chang Zu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Zu. The network helps show where Chang Zu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chang Zu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 76 | |
| 2 | 2018 | 61 | |
| 3 | 2020 | 38 | |
| 4 | 2016 | 33 | |
| 5 | 2017 | 27 | |
| 6 | 2016 | 24 | |
| 7 | 2017 | 17 | |
| 8 | 2016 | 17 | |
| 9 | 2013 | 13 | |
| 10 | 2020 | 13 | |
| 11 | 2020 | 11 | |
| 12 | 2016 | 11 | |
| 13 | 2023 | 6 | |
| 14 | 2022 | 1 |
About Chang Zu
Chang Zu is a scholar working on Pharmaceutical Science, Molecular Biology, Biomedical Engineering, Oncology and Biomaterials, having authored 14 papers that have together received 348 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (3 papers), Nanoplatforms for cancer theranostics (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Neurological Disease Mechanisms and Treatments (2 papers), Ginkgo biloba and Cashew Applications (2 papers), Crystallization and Solubility Studies (2 papers), Pharmacological Effects of Natural Compounds (2 papers) and Advanced Drug Delivery Systems (2 papers). The work is most often cited by research in Pharmaceutical Science (74 citations), Biomaterials (81 citations), Pharmacology (36 citations), Complementary and alternative medicine (30 citations) and Biomedical Engineering (97 citations). Chang Zu has collaborated with scholars based in China, Slovakia and United States. Frequent co-authors include Xiuhua Zhao, Yiping Deng, Mingfang Wu, Weiwei Wu, Ziqi Feng, Yuangang Zu, Lingling Wang, Jiasheng Tu, Dongsheng He and Yan Shen. Their work appears in journals such as RSC Advances, Journal of Colloid and Interface Science, European Journal of Pharmaceutical Sciences, International Journal of Pharmaceutics and Journal of Biomaterials Applications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.